The history of the Visian ICL procedure is a pretty interesting story. Soon enough, all the great innovations and technologies going on with the Visian ICL will be included in the history of the Visian ICL. It’s hard to imagine what the future will hold, especially when I can see 20/15 already after having the Visian ICL procedure. Let’s get to the history…
Italian surgeon Benedetto Strampelli was the first to successfully implant a phakic intra-ocular lens (pIOL) into the anterior chamber of the eye in order to correct myopia in 1953. That lens was manufactured by the Rayner company of Brighton, East Sussex, England from Perspex CQ Polymenthylmethacrylate made by Imperial Chemical Industries. This acrylic plastic material was chosen since it was inert. There were 239 implantations in 1959, but there were many complications associated with these implants. The complications experienced were chronic loss of corneal endothelial cells, iris retraction and atrophy, peripheral anterior synechiae and pupil ovalization. By the 1980s most of these lenses were phased out of the market because of the unacceptable complication rates and replaced with foldable models.
These new designs were manufactured by the Domilens Corporation and the NuVita MA 20 by Bausch and Lomb. These foldable designs allowed for the insertion of the pIOL through a smaller incision, thus reducing the probability of surgically induced astigmatism. Also, the switch was made from the anterior chamber angle supported pIOLs to the posterior chamber. This would allow a greater distance between the pIOL and the corneal endothelium. This location would also theoretically reduce the incidence of halos and glare as margins of the pupil would cover the border of the optical zones.
The most widely used posterior chamber pIOL is the Visian ICL V4, an implantable collamer lens manufactured by Staar Surgical Companies. The implantable collamer lenses were known as implantable contact lenses previously, and they were approved by the U.S. FDA in 2005. The FDA requested that the term implantable contact lenses be changed to avoid confusion with corneal contact lenses.
Unlike corneal refractive surgery, such as LASIK and PRK, the Visian ICL does not alter the structure of the eye, or involve tissue removal. Instead, the lens is inserted inside of the eye and works with the eye’s natural optical system (cornea and lens) to enhance its performance. The Visian ICL requires a small opening during a short surgical procedure with an almost immediate improvement in visual acuity. This extremely quick visual recovery is one of the many reasons surgeons choose this phakic IOL technology for vision correction. While the Visian ICL is meant to be a permanent solution for vision correction, the lenses are removable should the need ever arise. This benefit makes the Visian ICL an attractive alternative to corneal-based refractive surgery. The Visian ICL provides superior quality of vision compared to the results of corneal refractive procedures. It is the ideal choice for patients with the highest expectations of their refractive correction procedures. If you desire high quality results
Visian ICL Today
So many innovative techniques and technologies have become part of the history of the Visian ICL over the past several years, and many new innovations and technologies are being implemented today. Get together with your local Visian ICL surgeon and inquire about all the new innovations with the Visian ICL that are being implemented at this very moment. Soon there may be something even better for vision correction, but until then, the Visian ICL is top dog!